IOBCF (Ion Beam Applications) Cash Payments for Loans

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IOBCF Ion Beam Applications SA IOBCF
79 GF Score
Price $17.50
GF Value $17.88
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ion Beam Applications Cash Payments for Loans?

Cash Payments for Loans only applicable to companies reporting Cash Flow from Operations in direct method.

IOBCF
79GF Score
Ion Beam Applications SA IOBCF
Cash Payments for Loans is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ion Beam Applications (IOBCF) Overvalued in 2026?

Based on GuruFocus' analysis, Ion Beam Applications stock appears to be undervalued. The current stock price of $17.50 is trading 2.1% below its estimated GF Value™ of $17.88. GuruFocus considers Ion Beam Applications to be Fairly Valued.

Key valuation signals for IOBCF:

  • Cash Payments for Loans:
  • GF Value™: $17.88 vs. price of $17.50 (2.1% below fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ion Beam Applications Business Description

Address Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348
Ion Beam Applications SA (IBA) is a Belgian company that develops and manufactures particle accelerator technology for medical and industrial applications. Its core business is proton therapy systems for precision cancer treatment, where it supplies integrated turnkey solutions including accelerators, beam delivery, treatment planning software, and related services. IBA also produces cyclotrons used to generate radioisotopes for nuclear medicine imaging, and it sells dosimetry equipment for radiotherapy and medical imaging quality assurance. Its industrial accelerators are used for sterilization, ionization, and materials processing. The company serves hospitals, cancer treatment centers, radiopharmaceutical producers, and industrial customers. Revenue comes from equipment sales, long-term service and maintenance contracts, and software and upgrades. IBA operates internationally, with significant markets in Europe, the United States, and Asia, and maintains manufacturing and service operations across several countries.
79GF Score

Get the complete analysis for IOBCF

Cash Payments for Loans is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.50
Price
$17.88
GF Value